Search research articles
Contact Us
Filters
Showing results (321-330 of 418) with videos related to
Page
of 42
Sort By:
Dermatology and Therapy
|
December 12, 2022
Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2)
Paolo Gisondi, Alice B Gottlieb, Boni Elewski, et al.
JAAD International
|
July 23, 2024
Developing a questionnaire for assessing clinician- and patient-reported outcomes in actinic keratosis: Results from an expert panel
Brian Berman, April Armstrong, Mark Lebwohl, et al.
The Journal of Dermatological Treatment
|
April 6, 2018
Biological treatment for psoriasis and the risk of herpes zoster: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Guy Shalom, Luigi Naldi, Mark Lebwohl, et al.
Lancet (London, England)
|
July 13, 2020
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
David Rosmarin, Amit G Pandya, Mark Lebwohl, et al.
Journal of Drugs in Dermatology : JDD
|
September 4, 2024
Advances in Technology for Melanoma Diagnosis and Prognosis: An Expert Consensus Panel
Joshua Burshtein, Danny Zakria, Milaan Shah, et al.
Pharmacoeconomics
|
August 12, 2003
Validation of expert opinion in identifying comorbidities associated with atopic dermatitis/eczema
Charles N Ellis, Lynn A Drake, Mary M Prendergast, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
October 4, 2017
Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies
Mark Boguniewicz, Andrew F Alexis, Lisa A Beck, et al.
International Journal of Dermatology
|
November 1, 2015
Psychometric validation of the Psoriasis Symptom Diary using Phase III study data from patients with chronic plaque psoriasis
Bruce Strober, Yang Zhao, Mary Helen Tran, et al.
Journal of the American Academy of Dermatology
|
February 5, 2026
Apremilast Improves Skin Outcomes in Pediatric Plaque Psoriasis of Shorter Disease Duration: 52-Week Results From the SPROUT Phase 3 Trial
Richard G Langley, Lisa Arkin, Loretta Fiorillo, et al.
Journal of Drugs in Dermatology : JDD
|
February 23, 2019
Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in Practice
Mark Lebwohl, Andrew F. Alexis, Lisa A. Beck, et al.
Page
of 42
Search research articles
Search
Showing results (321-330 of 418) with videos related to
Sort By:
Page
of 42
Dermatology and Therapy
|
December 12, 2022
Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2)
Paolo Gisondi, Alice B Gottlieb, Boni Elewski, et al.
JAAD International
|
July 23, 2024
Developing a questionnaire for assessing clinician- and patient-reported outcomes in actinic keratosis: Results from an expert panel
Brian Berman, April Armstrong, Mark Lebwohl, et al.
The Journal of Dermatological Treatment
|
April 6, 2018
Biological treatment for psoriasis and the risk of herpes zoster: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Guy Shalom, Luigi Naldi, Mark Lebwohl, et al.
Lancet (London, England)
|
July 13, 2020
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
David Rosmarin, Amit G Pandya, Mark Lebwohl, et al.
Journal of Drugs in Dermatology : JDD
|
September 4, 2024
Advances in Technology for Melanoma Diagnosis and Prognosis: An Expert Consensus Panel
Joshua Burshtein, Danny Zakria, Milaan Shah, et al.
Pharmacoeconomics
|
August 12, 2003
Validation of expert opinion in identifying comorbidities associated with atopic dermatitis/eczema
Charles N Ellis, Lynn A Drake, Mary M Prendergast, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
October 4, 2017
Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies
Mark Boguniewicz, Andrew F Alexis, Lisa A Beck, et al.
International Journal of Dermatology
|
November 1, 2015
Psychometric validation of the Psoriasis Symptom Diary using Phase III study data from patients with chronic plaque psoriasis
Bruce Strober, Yang Zhao, Mary Helen Tran, et al.
Journal of the American Academy of Dermatology
|
February 5, 2026
Apremilast Improves Skin Outcomes in Pediatric Plaque Psoriasis of Shorter Disease Duration: 52-Week Results From the SPROUT Phase 3 Trial
Richard G Langley, Lisa Arkin, Loretta Fiorillo, et al.
Journal of Drugs in Dermatology : JDD
|
February 23, 2019
Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in Practice
Mark Lebwohl, Andrew F. Alexis, Lisa A. Beck, et al.
Page
of 42